Our vision is to deliver world-class innovative molecular imaging technologies and treatment strategies through education, research and collaboration.
BC Cancer operates a provincial Molecular Imaging and Therapy program with PET/CT imaging services available at its Vancouver, Victoria, and Kelowna locations. Since its launch in June 2005, the program has grown to support patients across the province, performing a high volume of procedures each year and contributing to improved access to advanced diagnostic imaging.
Figure 1. PET/CT scanner used to take detailed images of how your body is working.
In September 2010, BC Cancer opened a PET Cyclotron/Radiopharmacy at its Vancouver location. This PET Cyclotron/Radiopharmacy, licensed by Health Canada and the Canadian Nuclear Safety Commission, has enabled the program to manufacture and distribute clinical PET radiopharmaceuticals, such as, Fluorodeoxyglucose (FDG), on a provincial scale while also enabling research into new compounds.
The provincial Molecular Imaging and Therapy program aims to:
- Improve cancer diagnosis and treatment planning for patients and health care professionals
- Build research programs for the discovery, development and application of new radiotracers
- Apply new advances in imaging to improve prevention, early diagnosis and management of cancers
- Collaborate in a growing national and international network of functional imaging programs
BC Cancer Molecular Imaging and Therapy program provides professional, compassionate care for patients.
